Basilea launching antifungal CRESEMBA(R) (isavuconazole) in Germany
BASEL, Switzerland, March 4, 2016 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) hosts a symposium to support the launch of the new azole antifungal CRESEMBA® (isavuconazole) in Germany. The symposium will be held on March 5 and 6, 2016 in …